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APPENDIX V
THE SEBACEOUS-GLAND TEST
E. LONGSTAFF
SUNTZEFF and co-workers (1947) were
the first to postulate a significant role for
sebaceous glands in the chemical induc-
tion of cancer when the carcinogen was
applied topically. They observed that
neonatal mice were unresponsive to a
single dose of 20-methylcholanthrene but
3-day-old animals developed squamous-
cell carcinoma when similarly treated.
They noted also that repeated application
of the carcinogen produced regression of
the recipient's sebaceous glands.
These observations prompted Suntzeff
and his co-workers to investigate the
usefulness of this phenomenon for the
identification of potentially carcinogenic
tobacco-tar fractions. They concluded that
the sebaceous gland test was able to
discriminate between carcinogens and
non-carcinogens of this type, and the test
could be used to direct long-term efforts
towards the identification of carcinogens
in tobacco tars (Suntzeffet al., 1955, 1957).
Support for the validity of this test
also came from the investigation of Bock
and Mund (1958). They investigated a
large number of compounds, many of
which were ofknowncarcinogenicpotency.
Their results indicated that the degree of
sebaceous-gland suppression was roughly
parallel to tumour-producing capacity,
within a series of compounds containing
the benzanthracene nucleus. The test was
not reliable for all polycyclic aromatic
hydrocarbons since they reported that
some mouse-skin carcinogens (e.g. 7,9-di-
methylbenzacridine) in which the benzan-
thracene structure was absent, did not
destroy sebaceous glands. However, they
suggested that within the range of com-
pounds containing the benzanthracene
structure, the test was of value for
screening purposes. The conclusions of
Bock and Mund about the unreliability of
the method, together with the difficulties
encountered in measuring the decrease in
the numbers of sebaceous glands in the
treated Skins, resulted in the test falling
into disuse. Using new quantitative tech-
niques, the test was recently re-examined,
with particular reference to the potential
carcinogenicity of tobacco tars (Healy et
al., 1970, 1971) and was found to be
effective only with tobacco tars and
related chemicals.
The sebaceous-gland test has received
considerable support as a predictive test
by Chouroulinkov et al. (1969) for tobacco
fractions, and more recently by Takizawa
et al. (1975) for several nitrofuran deriva-
tives. It was therefore decided that the
test should be evaluated as a short-term
test for carcinogens, despite its apparent
limitations.
MATERIALS AND METHODS
The mice used were males of the specific-
pathogen-free Swiss-derived Alderley Park
strain. All mice used in the test were 55 days
old on arrival, and were kept for one week
before treatment. Mice of this age were
always used, because it has been shown that
the hair cycle can be important in the
reaction of the sebaceous glands to carcino-
gens (Suntzeff et at., 1955). A stable (telogen)
phase of the hair cycle in normal Swiss mice
reportedly exists between the ages of 48 and
78 days.
Generally, the test compounds were dis-
solved in dimethylsulphoxide (DMSO) con-
taining 10% v/v benzene, to yield a standard
solution of4 mg/ml. This gives a total dose of
2-4 mg test compound per mouse. When
solubility problems were encountered, other
solvent mixtures were used (DMSO: acteone
or DMSO water 50:50 v/v). The standard
test concentration was sometimes found to
damage the skin and on these occasions the
experiment was repeated at a lower dose, as
indicated in Table V.1.
Groups of 10 mice were shaved in the dorso-
lumber region with electric clippers and left
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overnight. Twice daily for the next 3 days
0 I ml oftest solution was applied by Pasteur
pipette to each shaved area. The animals were
then killed by cervical dislocation on the
4th day after cessation of treatment and
samples of test and control skin removed.
The skin was pinned epidermis down in
trays containing paraffin wax, fixed in
Bouin's fluid and then carefully orientated
in paraffin wax blocks so as to present their
sagittal plane to the microtome knife. This
technique produced comparable histological
sections ofskin, from which the percentage of
sebaceous glands to hair follicles could be
accurately determined. The mean and stan-
dard deviation of this percentage in each test
group of animals was calculated, in addition
to the percentage change in the number of
glands per follicle, and compared with the
several control groups taken as a whole,
using Student's t test.
A value of t > 1-960 (P = 0.05) indicated
a statistically significant difference between
the control and test ratios ofsebaceous glands
to hair follicles. An increase in the ratio of
glands to follicles in the treated animals was
taken to be ano-effect response from the point
of view of carcinogen screening.
An estimate of the degree of suppression
was also made, to aid in the assessment of
the alteration in the structure of the treated
skin. Thedegree ofsuppression was arbitrarily
classified as follows: Grade 3, at least 75% of
the glands suppressed; Grade 2, 50-74% of
the glands suppressed; Grade 1, less than
50% of the glands suppressed; and Grade 0,
glands not suppressed to a statistically
significant degree (which includes an in-
crease in number, i.e. a negative response).
Twenty-six compounds were tested over a
range of doses (i.e. 16, 8, 4, 2 and 1 mg/ml),
with a control group of 10 mice for each
group of compounds tested.
Compounds giving "false results" were
re-tested using a range of doses. From the
dose-response curves showing a positive
effect, it was possible to estimate the dose
level required to suppress the ratio of glands
to follicles by 50%. (This estimate was made
either by inspection of the dose-response
curve, or where considered appropriate, by
linear regression analysis.) This dose level
was designated the SG50 dose. It was possible,
therefore, to compare the SG50 levels of the
test compounds and relate this level to the
standard carcinogen, 3,4-benzpyrene.
RESULTS
A comparison of the percentage of
sebaceous glands to hair follicles of
control and treated skins at the standard
dose of4 mg/ml test compound demonstra-
ted that the sebaceous glands of mice
were sensitive to the action ofsome chemi-
cals. These results together with the
statistical significance and suppression
potency are given in Table T.1.
The results show the test to be 65%
accurate (Table V.1). Some compounds
giving "false results" were re-tested using
a range of doses. Only cyclophosphamide,
4-aminobiphenyl and 2-acetylaminofluor-
ene couldbeaddedto the list ofcarcinogens
which were identified. Mouse skin seba-
ceous glands seemed to be quite insensitive
to the action of benzidine, o-dianisidine,
dimethylnitrosamine, hexamethylphos-
phoramide or urethane. Some dose rela-
tionships were unusual (e.g. ethyl methane-
sulphonate and urethane) in that appa-
rently significant increases in the ratio of
sebaceous glands to follicles were seen.
Non-carcinogens such as biphenyl and
2,4,5-trichlorophenoxyacetic acid, which
previously gave a positive response, were
now seen to give negative or at least
equivocal responses.
DISCUSSION
The sebaceous-gland-suppression test
in mice for the identification of potential
carcinogens has been reviewed and eval-
uated.
In general, the results of the current
validation study agreed well with the
published findings of other workers, and
in particular the predictive value of the
test was good when assaying polycyclic
aromatic hydrocarbons.
The t test was used to distinguish
between significant and non-significant
events. A statistically significant reduc-
tion in the ratio of glands to follicle was
taken to indicate carcinogenic potential.
In addition, the percentage change in the
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TABLE V.1.
Compound
Acridine
2-Acetylaminofluorene
4-Acetylaminofluorene
Aflatoxin B
4-Aminoazobenzene
2-Aminobiphenyl
4-Aminobiphenyl
2-Aminochrysene
6-Aminochrysene
3-Aminopyrene
2-Aminonaphthalene-1 -
sulphonic acid
Aniline
p-Anisidine
Anthracene
2-Aminoanthracene
Anthranilic acid
Anthraquinone
Anthrone
1,2-Benzanthracene
Benzanthrone
Benzidine
Benzimidazole
Benzoic acid
3,4-Benzpyrene (2 mg/ml)
6-Benzoyl-2-naphthol
Biphenyl
Bis azo compound
Bis(Chloromethyl)ether
N,N'-Bis(2-naphthyl)-p-
phenylenediamine
Butanesultone
Caffeine
Calmagite
Camphor
Carbazole
Chlorambucil
Chloramine T
Cholesterol
Colchicine (2 mg/ml)
Croton oil
Cyanocobalamin (B12)
Cycasin acetate
Cyclohexylamine
Cyclophosphamide
3,3'-Diaminobenzidine
2,7-Diaminofluorene
3,4,5,6-Dibenzacridine
1,2,3,4-Dibenzanthracene
3,4,9,10-Dibenzpyrene (2 mg/ml)
3,3'-Dichlorobenzidine
2,4-Dichlorophenoxyacetate
Dicyclohexylamine
D.D.T.
Dieldrin
Diethylnitrosamine
Diethylstilboestrol
3,3'-Dimethoxybenzidine
4-Dimethylaminoazobenzene
9,10-Dimethylanthracene
p-Dimethylaminobenzaldehyde
7,9-Dimethylbenzacridine
7,10-Dimethylbenzacridine
9,10-Dimethyl-1,2-benzan-
thracene (2 mg/ml)
Mean %
Glands/Follicle
±s.d.
60-9+8*-2
64-2±14-3
NT
7-9±4-2
32-8±13-5
54-8±10-6
50*4±13-5
35-7±A-22-1
20-5±13-5
57-7±14-1
47-5±18-3
61 -9±13-7
40 2±11-2
65-0±14-6
44-512-1
75 -9±6 -4
40-4±12-4
55-4±18-5
6-1±10-3
54-1±21-3
47-0±13 -4
53-8±11 -7
53-6±13 -9
18-1±22-1
45-1±6- 7
42-8±12-5
43 0±13-7
14 4±9 2
46-4±16-8
40-2±17-1
43-9±13 -3
38-9± 7-6
40 1±11 .0
53-3±12 -3
25-7±9-8
63-5±15 -0
57-7±11 6
5-5±6-5
18 7±11-1
59 -1±11-4
35-9±14-8
36-6±13-0
68-5±5-6
38 9±11 0
48-0±19-8
10-4±10-8
9-8±7-6
20-3±16-7
61*9±14-8
63 -7±10-3
50-0±17-6
66-8±17-9
46-9±16-4
61 0±11-7
59 4±8-9
29-0±13 -6
59-9±10-9
2 5±5-1
52-8±9-7
6-0± 7 - 7
2-22±05
11* 9±13.4
% Change
+7-8
+13-6
NT
-86 0
-41-9
-3 0
-10-8
-36-8
-63-7
+2-1
-15-9
+9-6
-28-8
+15-0
-21 -2
+34-3
-28-5
-1-9
-89 -2
-4-2
-16-8
-4-8
-5-1
-68 0
-20-2
-24-2
-23-9
-74-5
-17-9
-28-8
-22 -3
-31 -2
-29 0
-5-7
-54-5
+12-4
+2-1
-90 3
-66-9
+4-6
-36 -5
-35 -2
+21 -2
-31-2
-15-0
-81 -6
-82-7
-64-1
+9-6
+12-7
-11-5
+18-2
-17-0
+8-0
+5-1
-48-7
+6-0
-95-6
-6-6
-89-4
-96-1
-78-9
t
1 -496
1 -626
NT
25 -465
3 -880
0 470
1-3616
2 -916
8 037
0 257
1 -517
1 -187
4 -296
1 - 766
2-957
7-917
3 - 699
0-183
14 -831
0 348
2-133
0 652
0-631
5-394
4 505
4-184
2 -983
12 -533
1 -842
2-787
2 -851
6-362
4.373
0 776
9-125
1 -420
0 307
18 - 962
10-031
0 673
3 *577
4 370
5 -358
4- 722
1 -328
12 -573
16 -825
6- 620
1 -105
1 - 946
1 -132
1 -767
1 - 789
1 -139
0 928
6 -082
0-914
25-416
1 -103
18 -089
39 -342
10-030
Prediction
Test result from
and potency literature
-0 -
-0 +
NT -
+3 +
+1 +
-0 +
-0 +
+1 +
+2 +
-0 -
-0 -
-0 -
+1 -
-0 -
+1 +
-0 -
+1 I
-0 -
+3 +
-0 -
+1 ±
-0 -
-0 -
+2+ +
+0 - +1 _
+1 _
+2 +
-0 -
+1 +
+1 _
+1 _
+1 _
-0 -
+2 +
-0 -
-0 -
+3+ _
+2 +
-0 -
+1 +
+1 _
-0 +
+1 _
-0 +
+3 +
+3 +
+2+ +
-0 +
-0 -
-0 -
-0 -
-0 -
-0 +
-0 +
+1 +
-0 +
+3 +
-0 -
+3 +
+3 +
+3+ +
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TABLE V.1-continued.
Compound
1,1'-Dimethyl-4,4'-
bipyridinium dichloride
3,3'-Dimethylbenzidine
Dimethylcarbamoyl chloride
Dimethylformamide
Dimethylnitrosamine
2,3-Dimethylquinoxaline
Dinitrobenzene
2,4-Dinitrofluorobenzene
2,4-Dinitrophenol
Dinitrosopentamethylene
tetramine
DL-Ethionine
1,1'-Ethylene-2,2'-
bipyridinium dibromide
Ethylenethiourea
Ethyl methanesulphonate
Hexachlorocyclohexane
Hexamethylphosphoramide
Hydrazine
Hydrocortisone
Indole
Merchlorethamine
20-Methylcholanthrene (2 mg/ml)
Methylene bis(2-chloroaniline)
2-Methylindole
MNNG
3-Methyl-4-nitroquinoline-N-
oxide
Mitomycin C (2 mg/ml)
Morgan's base
Naphthalene
I-Naphthol
2-Naphthol
1-Naphthylamine
2-Naphthylamine
2-Naphthylamine disulphonic
acid
Nitrobenzene
2-Nitrobiphenyl
4-Nitrobiphenyl
2-Nitrofluorene
N-Nitrosodiphenylamine
N-Nitrosoephedrine
N-Nitrosofolic acid
4-Nitroquinoline-N-oxide
4-Nonylphenol/ethylene
oxide condensate
Orotic acid
Perylene
Phenobarbital
N-phenyl-2-naphthylamine
Propanesultone
,-Propiolactone
Resorcinol
Riboflavin
Safrole
3,3',5,5'-Tetramethylbenzidine
Toluene
Toluene-2,4-diisocyanate
2,4,5-Trichlorophenoxyacetate
Trimethylphosphate
Urethane
Vinyl chloride (61 mg/ml)
Controls (138 samples)
Mean %
Glands/Follicle
±s.d.
27-2±+17-6
44-3±15-2
48-4±9-4
58-5±18-9
51-3±14-5
15 4±9*0
41-4±10-9
5-8±8 .4
44-2±20-2
61- 7±16-2
69-6±10-2
17-6+±18-8
49-9±14-6
38-5±12 -1
55 -2±16 - 7
52-4±12 -1
47-1±9-5
32-5±13-7
31-2±13-6
2-9±3 -5
7 0±7 5
31-5±13-7
58-24 17-6
27 -9± 17 -0
74-6±7-8
13 -6±9-9
17-0±11 -3
50-9±14-6
66 - 1±11 - 6
60-3±9-7
51 - 7±9 -9
24- 6±8 -2
53 -3± 10 -4
54-8±15-7
71 3±8-4
42-0±15-9
72-0±8 - 9
40-7±16-3
41 -6±11 -5
48-7±10-9
1 0 (estim)
52-2±9 - 7
35-048 - 8
69-0±13-4
38-2±16-9
45-1±17-8
55-3± 12-9
44-8±14-4
54-2 7 -3
450±19-9
32-8±12-3
67 1±11 9
60-7±15-1
63-1±9-9
421 15 -0
60 0±14-0
51 -2±11 - 6
42-6± 16-5
56 -5±16 -1
% Change
-51 9
-21-6
-14-3
+3-5
-9-2
-72-7
-26-7
-89-7
-21 8
+9-2
+23 -2
-68-9
-11* 7
-31 -9
-2-3
-7-3
-16-6
±42-5
-44-8
-94-9
-87 -6
-44-2
+3 0
-50-6
+32 0
-75-9
-69 -9
-9.9
+17-0
+6-7
-8-5
-56-5
-5-7
-3 0
+26-2
-25-7
+27-4
-28-0
-26-4
-13-8
-98-2
-7-6
-38-1
+22-1
-32 -4
-20-2
-2-1
-20-7
-4-1
-20-4
-41 -9
+18-8
+7 4
+11 7
-25-5
+6 -2
-9 4
-24 6
0
t
4- 852
2 -447
2-464
0 326
1 -087
13 -073
4-255
16-960
1 - 879
0- 982
3 - 738
6
- 371
1 .369
4-428
0-239
1 -009
2-446
5-271
5
- 609
30 -571
18-155
4 -966
0 -296
4-902
6-418
12 -550
10- 308
1 -163
2-449
1 -135
1 -403
10 -920
0 898
0 330
4 950
2 -641
1-449
2-960
3 -834
1 - 796
1 -96
1 -22
6 -934
2 -798
3 -299
1 -972
0-278
2 -459
0-585
1 -785
5- 747
2 -652
0-845
1 -933
2-916
0-756
1 .354
2-571
Prediction
Test result from
and potency literature
+2
+1 +
+1 +
-0 -
-0 +
+2 _
+1 _
+3 +
-0 -
-0 -
-0 +
+2
-0 +
+1 +
-0 -
-0 +
+1 +
+2
+2
+3 +
+3+ +
+1 +
-0 -
+2 +
-0 -
+3+ +
+2 +
-0 -
-0 -
-0 -
-0 -
+2 +
-0 -
-0 -
-0 +
+1 +
-0 +
+1
+1 +
-0 +
+3 +
-0 -
+1
-0 -
+1
+1
-0 +
+1 +
0O -
-0 -
+1 +
-0 -
-0 -
-0 -
+1 _
-0 -
-0 +
+1 +
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ratio ofglands to follicles appeared to vary
between one compound and the next, such
that the suppression potency of the test
compound could be ranked between 0
(no significant effect) and 3 (more than
75% of the glands destroyed). Even so,
out of 29 compounds causing more than
50% suppression (i.e. grades 2 and 3), 6
were false positives. These compounds
were colchicine, dimethylquinoxalene 1,1'-
dimethyl-4,4'-bipyridinium dichloride, hy-
drocortisone, indole and ,1'-ethylene-2,2'-
bipyridinium dibromide.
When the dose-response curves ofa limi-
ted number of compounds were investiga-
ted, it was seen that the system could be
made quantitative, in that the dose
equivalents of compounds causing 50%0
gland suppression could be calculated,
compared with each other, and related to
the activity of benzpyrene. It is, however,
debatable whether or not this suppression
index has any real value in terms of pre-
dicting carcinogenic potency since it could
beseenthatknownpotent carcinogens such
as aflatoxin appeared to be less active than
other potent carcinogens such as benz-
pyrene. It could be speculated however
that the relative carcinogenic potencies of
similar chemicals, e.g. polycyclic aroma-
tics, could be compared using their
respective suppression indices, on the
assumption that the mechanism of seba-
ceous-gland suppressionineach case would
be similar. Clearly, it would not, however,
be valid to compare chemicals of different
classes for potency using this technique.
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